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Abstract
Members of the genus Acinetobacter have been the focus recent attention due to both their clinical significance and
application to molecular biology. The soil commensal bacterium Acinetobacter baylyi ADP1 has been proposed as a model
system for molecular and genetic studies, whereas in a clinical environment, Acinetobacter spp. are of increasing importance
due to their propensity to cause serious and intractable systemic infections. Clinically, a major factor in the success of
Acinetobacter spp. as opportunistic pathogens can be attributed to their ability to rapidly evolve resistance to common
antimicrobial compounds. Whole genome sequencing of clinical and environmental Acinetobacter spp. isolates has revealed
the presence of numerous multidrug transporters within the core and accessory genomes, suggesting that efflux is an
important host defense response in this genus. In this work, we used the drug-susceptible organism A. baylyi ADP1 as a
model for studies into the evolution of efflux mediated resistance in genus Acinetobacter, due to the high level of
conservation of efflux determinants across four diverse Acinetobacter strains, including clinical isolates. A single exposure of
therapeutic concentrations of chloramphenicol to populations of A. baylyi ADP1 cells produced five individual colonies
displaying multidrug resistance. The major facilitator superfamily pump craA was upregulated in one mutant strain, whereas
the resistance nodulation division pump adeJ was upregulated in the remaining four. Within the adeJ upregulated
population, two different levels of adeJ mRNA transcription were observed, suggesting at least three separate mutations
were selected after single-step exposure to chloramphenicol. In the craA upregulated strain, a T to G substitution 12 nt
upstream of the craA translation initiation codon was observed. Subsequent mRNA stability analyses using this strain
revealed that the half-life of mutant craA mRNA was significantly greater than that of wild-type craA mRNA.
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Introduction
Acinetobacter spp. are ubiquitous environmental organisms, and
are readily isolated from soil, water, human skin, food items, and
sewage effluent. Over the past decade, Acinetobacter spp. have
become the specific focus of increased research interest due to two
disparate reasons. Firstly, the non-pathogenic soil-dwelling
Acinetobacter species, A. baylyi ADP1, has been proposed as an
alternative model for molecular, genetic, and metabolic studies,
since this organism is naturally transformable, genetically mallea-
ble, and nutritionally diverse [1,2,3]. Laboratory studies using A.
baylyi ADP1 are facilitated by the capacity of the organism to be
transformed with exogenous DNA, in either linear or plasmid
form, simply by incubating the DNA samples with logarithmic-
phase A. baylyi ADP1 cells [2]. Moreover, integration of foreign
DNA into the A. baylyi ADP1 chromosome occurs at high
frequencies, without the need for extensive regions of homology to
be present on transfected DNA molecules [1]. Secondly, despite
occupying diverse environmental niches, most of the 31 described
Acinetobacter genomospecies have the capacity to cause disease in
humans [4]. Acinetobacter spp. have been estimated to cause up to
10% of all Gram-negative hospital infections and, alarmingly, may
result in a mortality rate of between 30 and 75% [5]. In a clinical
context, Acinetbacter spp. present a significant challenge since
hospital strains which have emerged over the last decade have
frequently acquired resistance to all practicable antimicrobial
compounds, including drugs reserved for serious multidrug
resistant infections [6]. Antimicrobial resistance in Acinetobacter
spp. can be acquired via horizontal gene transfer (HGT) of
preformed genes carried on plasmids, transposons, and integrons,
or can be can be a result of the mutation of endogenous genes
resulting in a resistance phenotype, as in the case of the
upregulation of chromosomally encoded multidrug efflux systems
[7]. To date, nine multidrug efflux systems have been char-
acterised or partially characterised in Acinetobacter spp: RND
transporters AdeABC, AdeDE, AdeIJK, and AdeFGH; MFS
transporters AdeF/AmvA, CraA AedC and Tet(A); MATE
transporter AbeM, and SMR transporter AbeS (reviewed in [8]).
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Transcriptional upregulation of RND transporters AdeABC, and
AdeIJK results in increased antimicrobial resistance in clinical
strains, while deletion or insertional inactivation of components of
AdeABC, AdeDE, AdeIJK, AdeFGH, CraA, and AbeS has
established a causal relationship between the presence of the
transporter and high-level or intrinsic resistance of Acinetobacter spp.
to one or more antimicrobial compounds [8].
In this work we used the non-pathogenic environmental
Acinetobacter species A. baylyi ADP1 as a model for studies on the
evolution of efflux-mediated antimicrobial resistance in the genus
Acinetobacter. A. baylyi ADP1 offers several advantageous traits for
studies on the genetic basis of resistance in Acinetobacter spp.,
including; (1) high level of conservation of ‘core’ genes (i.e., genes
which are conserved across all Acinetobacter species) between A.
baylyi ADP1 and other members of the Acinetobacter genus
[9,10,11]; (2) high level of susceptibility of A. baylyi ADP1 to most
commonly used chemotherapeutic agents [12]; (3) absence of
strongly transcribed resistance gene determinants in A. baylyi
ADP1 [12], enabling analysis of the development of resistance in
an essentially resistance-free context; (4) natural transformability
and recombinogenicity of A. baylyi ADP1 [2]; and (5) significant
genome plasticity of A. baylyi ADP1 [2,13], which is of particular
importance in the evolution of antimicrobial resistance [14].
Results
Putative multidrug exporters encoded in Acinetobacter
are commonly found within the core genome
Multidrug exporters encoded within Acinetobacter spp. sequenced
genomes were identified using the Transporter Automated
Analysis Pipeline (TransAAP; www.membranetransport.org)
[15]. The TransAAP uses a suite of tools to predict an organism’s
complete complement of membrane transport proteins from its
predicted proteome [15]. Four diverse Acinetobacter spp. genomes
were used for TransAAP multidrug transporter prediction: the soil
commensal strain A. baylyi ADP1, clinical strains A. baumannii
ATCC 17978 and A. baumannii AYE, and the human louse isolate
A. baumannii SDF. Surprisingly, it was predicted that A. baylyi
ADP1 encodes 46 multidrug transporters, almost as many as
clinical strains A. baumannii ATCC 17978 (50), and A. baumannii
AYE (55) (Fig. 1). The human louse isolate A. baumannii SDF,
which is hypothesised to have undergone multiple rounds of
genome reduction [10], encodes 31 putative multidrug transport
proteins. Twenty-one multidrug transporters are predicted to be
conserved across all four Acinetobacter genomes (Fig. 1).
Evolution of Chloramphenicol Resistance in A. baylyi
ADP1 Has Consequences for Bacterial Fitness
Single-step selection of A. baylyi ADP1 chloramphenicol resistant
mutants was achieved by plating 2.086108 CFU of wild-type A.
baylyi ADP1 cells onto Nutrient Agar (NA) containing either 10 or
20 mg/ml chloramphenicol. After 16 hours incubation at 37uC,
three individual colonies were present on the plate containing
10 mg/ml chloramphenicol, and two on the plate containing
20 mg/ml chloramphenicol. Chloramphenicol resistant A. baylyi
ADP1 strains selected on 10 mg/ml chloramphenicol were named
Cm101, Cm102, and Cm103, and those selected on 20 mg/ml
chloramphenicol were named Cm201 and Cm202 (Table 1).
To assess the effect of acquired chloramphenicol resistance on
bacterial fitness, we monitored the growth of mutant and wild-type
A. baylyi ADP1 strains in rich medium (Meuller-Hinton; MH) over
a time course of 15 hours (Fig. 2). Cm101, Cm102, Cm103 and
Cm201 did not grow at a rate statistically significantly different to
that of wild-type A. baylyi ADP1 (Table 2), despite having slightly
longer doubling times in comparison to that of the wild-type strain.
In contrast, strain Cm202 exhibited a significant growth defect
compared to wild-type ADP1 (P-value 0.017; Table 2). Both the
growth rate and the final cell density of Cm202 were markedly
reduced compared to that of the wild-type strain, indicating that
the development of chloramphenicol resistance in Cm202 was
particularly deleterious to the fitness of the strain under non-
selective conditions. Growth characteristics of strain Cm202 in
comparison to other mutant strains suggested that mutations
involved in the development of chloramphenicol resistance may
differ between the single-step resistance mutants.
Single-Step A. baylyi ADP1 Mutant Strains Exhibit
Multidrug Resistance
To determine if the resistance spectrum of mutant strains
extended beyond chloramphenicol, we conducted Minimal
Inhibitory Concentration (MIC) analyses using a range of
structurally and functionally diverse antimicrobial compounds.
Multiple drug resistance phenotypes were observed for all single-
step resistance mutants (Table 3). Such broad resistance profiles
are often indicative of overexpression of multidrug efflux systems.
The resistance phenotypes detected were not uniform between
mutant strains, particularly between the resistance profile observed
for strain Cm201 and the remainder of the resistant strains.
Cm201 exhibits a relatively narrow multidrug resistance pheno-
type, showing two-fold increases in resistance to chloramphenicol,
ethidium bromide and tetracycline. In comparison, Cm101,
Cm102, Cm103 and Cm202 exhibit increased resistance levels
to a much wider spectrum of drugs, albeit with differences in
resistance levels between some strains, e.g., Cm202 shows a two-
fold higher MIC for chloramphenicol, norfloxacin and tetracycline
when compared to that of the other mutant strains. This marked
difference in the efflux profile of Cm201 compared to that of the
other single-step mutant strains suggested that a different
transporter(s) was responsible for the substrate specificity exhibited
by this strain. None of the mutant strains exhibited MICs greater
than that of wild-type A. baylyi ADP1 for colistin, DAPI,
kanamycin or amikacin (data not shown).
Figure 1. Venn diagram depicting conservation of putative
drug efflux transporters encoded within representative se-
quenced strains of Acinetobacter. Each strain is represented by a
colored oval, A. baumannii SDF (blue), AYE (red) and ATCC 17978
(yellow) and A. baylyi ADP1 (green). The number of efflux systems was
determined using TransAAP. Numbers in brackets after strain names are
the number of putative efflux systems encoded in that strain. Numbers
in overlapping regions are the number of systems shared by those
strains, as determined by comparative BlastP searches.
doi:10.1371/journal.pone.0056090.g001
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Multidrug Resistance in Single-Step Mutants is a Result of
Active Efflux
Each of the mutant strains exhibited an increased level of
resistance to ethidium bromide when compared to the wild-type
strain. Therefore, to confirm efflux as the mechanism of resistance
in the single-step mutants, we conducted fluorimetric ethidium
bromide transport assays. Each of the mutant strains was shown to
actively export ethidium bromide at a rate significantly greater
than the wild-type strain (Fig. 3). Of note, the rate of ethidium
bromide efflux was not uniform across all of the mutant strains,
further strengthening the hypothesis that different exporters were
responsible for the resistance phenotypes observed in the different
mutant strains. Interestingly, the initial rate of ethidium bromide
efflux from strain Cm201 was far greater than that from the other
single-step mutants, despite this strain displaying a lower overall
ethidium bromide resistance level.
Multidrug Resistant A. baylyi Mutants Exhibit
Upregulation of Different Efflux Pumps
To identify multidrug efflux pumps involved in resistance
phenotypes observed for mutant strains, we performed quantita-
tive real-time PCR (qRT-PCR). Data generated using TransAAP
Table 1. Bacterial strains, plasmids and primers.
Strain, plasmid or primer Genotype or relevant characteristicsab
Source or
reference
Strains
Acinetobacter baylyi ADP1 wild-type (ATCC 33305) (Juni and Janik, 1969)
Cm101 A. baylyi ADP1 efflux mutant selected on 10 mg/ml Cm This study
Cm102 A. baylyi ADP1 efflux mutant selected on 10 mg/ml Cm This study
Cm103 A. baylyi ADP1 efflux mutant selected on 10 mg/ml Cm This study
Cm201 A. baylyi ADP1 efflux mutant selected on 20 mg/ml Cm This study
Cm202 A. baylyi ADP1 efflux mutant selected on 20 mg/ml Cm This study
ADP1DadeJ A. baylyi ADP1 with adeJ deleted via allelic replacement. KanR This study
Cm101DadeJ Cm101 with adeJ deleted via allelic replacement. KanR This study
Cm202DadeJ Cm202 with adeJ deleted via allelic replacement. KanR This study
ADP1DcraA A. baylyi ADP1 with craA deleted via allelic replacement. KanR This study
Cm201DcraA Cm201 with craA deleted via allelic replacement. KanR This study
Plasmids
pENTR/SD/D-TOPOH 2.6 kb Gateway Entry Vector; source of kanamycin resistance marker for gene knock-outs. Invitrogen
Primers
Kan-F TAGCTGTTTCCTGGCAGCTC
Kan-R TCCCGTCAAGTCAGCGTAAT
Kan-SCRN-R GCCTGAGCGAGACGAAATAC
AdeJ-FRONT-F CGGTTACACGTACACCAACG
AdeJ-FRONT-R GAGCTGCCAGGAAACAGCTATCAGTCTACTCCTTATGCATGT
AdeJ-BACK-F ATTACGCTGACTTGACGGGATGCAAAAAGTATGGTCTATTTCAG
AdeJ-BACK-R CCAATTGTTGGAAGCTGGTT
AdeJ-SCRN-F TTGGCATTTTCTGATGCAAG
CraA-FRONT-F CTCTCGGCTTAAAATGTGGA
CraA-FRONT-R GAGCTGCCAGGAAACAGCTATTTGCATTGTGATCTACTAATCAA
CraA-BACK-F ATTACGCTGACTTGACGGGATCTGTTTGAAGCTCTGATATGTC
CraA-BACK-R ATCTCTGCTTTGGGGAGTCA
CraA-SCRN-F AAATGCAGCAATATGCAAAAGA
AdeI_upF GACGACGCATTTTGATGATG
AdeI_upR AAGCCTGATTCATCCACCAC
AdeJ_upF GCCGAGTTCGTTTTGAACAG
AdeJ_upR GCCACCAATGTTGAACACAC
AdeK_upF CGCGAGTCTATGCTGGAGTA
AdeK_upR CCAGCCTGTTCAGCATTTTT
CraA_upF GCATAACCGACCGCAGTAAT
CraA_upR ATAACGAGCCATGTCCTGCT
aCm: chloramphenicol.
bKanR: kanamycin resistant.
doi:10.1371/journal.pone.0056090.t001
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(see above) was used to design oligonucleotides to all 46 multidrug
efflux pumps predicted to be encoded within the A. baylyi ADP1
chromosome. These primer sets were then employed in a high-
throughput, qRT-PCR-based genome-wide survey of multidrug
efflux pump transcription. Basic data generated in this survey was
used to identify transporters which were strongly upregulated (.5
fold), and these transporters were subjected to further qRT-PCR-
based analysis. Preliminary qRT-PCR analyses determined that in
each of the chloramphenicol resistant strains, only one putative
multidrug efflux system was significantly upregulated (data not
shown). As predicted from drug resistance and ethidium bromide
transport phenotypes, qRT-PCR outputs indicated that not all
single-step selected multidrug resistant A. baylyi ADP1 strains
exhibit upregulation of the same efflux determinant (Table 4).
Strains Cm101, Cm102, Cm103 and Cm202 showed upregulation
of the gene ACIAD2944, whereas in Cm201 ACIAD3292 was
upregulated. The qRT-PCR analyses also revealed differences in
the level of upregulation of the efflux pump transcripts between
the mutant strains (Table 4). Strains Cm101, Cm102, Cm103
(selected on 10 mg/ml chloramphenicol) show over 5-fold
upregulation of ACIAD2944, whereas strain Cm202 (selected on
20 mg/ml chloramphenicol) shows nearly an 8-fold upregulation of
the same gene. This increased upregulation of ACIAD2944 in
Cm202 compared to the other mutant strains may account for its
reduced fitness (Fig. 2). In contrast, Cm201 shows upregulation of
ACIAD3292 at a level 34.4 fold higher that wild-type ADP1, with
limited observed deleterious effects to bacterial growth.
Mutant Strains Exhibit Upregulation of Functionally
Distinct Transporters: RND adeJ or MFS craA
BLASTP searches revealed that ACIAD2944 exhibits 89%
identity to the A. baumannii RND pump AdeJ [16], whilst
ACIAD3292 exhibits 80% identity to the A. baumannii DHA1
MFS pump CraA [17]. The upregulation of these different classes
of efflux pumps is of particular note, since this phenomenon
illustrates a functional redundancy involved in the evolution of
exporter-mediated resistance in Acinetobacter spp. in response to
challenge with inhibitory concentrations of antibiotics. To
examine the relatedness of the proteins encoded by ACIAD2944
and ACIAD3292 with a broad range of other RND and DHA1
MFS transporters (within the TCBD; www.tcdb.org), we conduct-
ed pairwise similarity analyses (Datasets S1 and S2). These
analyses indicated that ACIAD2944 and ACIAD3292 are close
orthologs of their A. baumanni AdeJ and CraA counterparts, since
they share significantly higher levels of similarity with these
proteins than with other RND or MFS transporters, respectively
(Datasets S1 and S2). Further support for this observation is
apparent in phylogenetic analyses of the proteins, i.e., the majority
of drug exporting RND proteins encoded in A. baumannii share a
close ortholog in A. baylyi ADP1 (Fig. 4).
Deletion of adeJ or craA Induces Antimicrobial-
Hypersusceptibility in A. baylyi ADP1
In order to confirm that the AdeJ (ACIAD2944) or CraA
(ACIAD3292) transport proteins are independently responsible for
the observed multidrug resistance phenotypes in single-step
mutants, we deleted the adeJ or craA genes in both the drug
resistant and wild-type A. baylyi ADP1 strains (Table 1), and
conducted MIC assays on the resultant deletion derivatives. adeJ
was not deleted in Cm102 and Cm103, since these strains exhibit
an identical multidrug resistance profile to Cm101.
The deletion of either adeJ or craA resulted in the complete
abrogation of resistance phenotypes observed in the respective
mutant strain backgrounds (Table 3), indicating that the upregula-
tion of the respective transporters was solely responsible for the
resistance phenotypes observed. Moreover, and of particular note,
we observed both adeJ and craA deletion derivatives showed hyper-
susceptibility phenotypes for a range of compounds tested
(Table 3). adeJ knockout strains show a reduction in MIC values
of at least two fold (and up to 16 fold) in comparison to wild-type
against all compounds tested. In contrast, craA deletion derivatives
showed a decreased MIC for chloramphenicol and ethidium
bromide only. Upregulation of craA transcription resulted in a
modest increase in the MIC for tetracycline, however, the deletion
of this gene does not result in a hyper-susceptibility phenotype for
this compound. Hyper-susceptibility phenotypes observed here
suggest that both adeJ and craA transport complexes play an
important role in the homeostasis of toxic compound efflux in
Acinetobacter spp.
Figure 2. Growth characteristics of wild-type A. baylyi ADP1 or
A. baylyi ADP1 single-step mutants over a time-course of
15 hours. Saturated overnight cultures of A. baylyi ADP1 strains were
inoculated in fresh MH media to an OD600 of 0.01 in a volume of 200 ml
prior to incubation at 37uC with shaking. Growth assays were
conducted in duplicate using three biological replicates. Standard
deviation is shown.
doi:10.1371/journal.pone.0056090.g002
Table 2. Growth characteristics of wild-type and mutant A.
baylyi strains.
Strain Doubling time (m)a P-valueb
Wild-type ADP1 98.1762.03 N/A
Cm101 109.8869.58 NSD
Cm102 116.6568.37 NSD
Cm103 112.0663.85 NSD
Cm201 110.0268.19 NSD
Cm202 149.7269.71 0.017
am: minutes. Standard Error is shown.
bPaired Student’s t-test was used to determine if the exponential growth rates
of mutant strains were significantly different than that of wild-type A. baylyi
ADP1. A P-value below 0.025 indicates statistical significance. N/A: not
applicable; NSD: no significant difference.
doi:10.1371/journal.pone.0056090.t002
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To determine if the growth rates of A. baylyi strains in which
either adeJ or craA were deleted were different to that of the wild-
type strain, we conducted bacterial growth assays, essentially as
described above. Interestingly, statistical analysis of this growth
data showed that the deletion of adeJ in Cm202 (Cm202DadeJ)
ameliorated the growth defect which was previously observed for
this strain (data not shown). This result suggests that the ,8-fold
upregulation of adeJ in Cm202 is responsible for the observed
differences in the growth rate of this strain in comparison to wild-
type cells. The growth rates of wild-type A. baylyi ADP1 or other
mutant strains in which efflux pumps had been deleted were not
statistically different to that of the wild-type strain.
Sequencing of Putative Transporter Regulatory Regions
Reveals Differences in the Basis for adeJ and craA
Upregulation
In an effort to determine the basis for the upreglation of efflux
pump mRNA transcription in A. baylyi ADP1 single-step mutants,
we sequenced regions upstream of structural genes encoding the
AdeIJK and CraA efflux pump modules. This sequencing strategy
would enable mutations potentially affecting promoters or
regulatory motifs of the core pump genes to be identified. Genes
encoding the A. baylyi ADP1 AdeIJK proteins reside in a region
which is syntenous to the adeIJK operon in A. baumannii AB0057
([16], data not shown), suggesting it is also an operon.
Nevertheless, we sequenced across intergenic regions both
upstream of and within the adeIJK operon, in single-step mutants
which upregulate the transcription of adeJ. No mutations were
found, indicating that a potential mutation elsewhere in the
genome, possibly affecting expression of a global transcriptional
regulator, may be responsible for the derepression of adeIJK.
Similarly, A. baumannii AB0057 single-step mutants which exhibit
upregulated transcription of adeJ [18] did not exhibit mutations
Table 3. MIC of compounds tested against A. baylyi ADPI strains.
MIC (mg/ml)ab
Strain Cm Et Bc Ch SDS Nor Tc Tm
Wild-type ADP1 6 16 5 2.5 400 1.024 0.1875 22.5
Cm101 12 (2) 128 (8) 10 (2) 5 (2) 800 (2) 4.096 (4) 0.75 (4) 90 (4)
Cm102 12 (2) 128 (8) 10 (2) 5 (2) 800 (2) 4.096 (4) 0.75 (4) 90 (4)
Cm103 12 (2) 128 (8) 10 (2) 5 (2) 800 (2) 4.096 (4) 0.75 (4) 90 (4)
Cm201 12 (2) 32 (2) 5 (0) 2.5 (0) 400 (0) 1.024 (0) 0.375 (2) 22.5 (0)
Cm202 24 (4) 128 (8) 10 (2) 5 (2) 800 (2) 8.192 (8) 1.5 (8) 90 (4)
ADP1DadeJ 1.5 (24) 4 (24) 2.5 (22) 1.25 (22) 25 (216) 0.064 (216) 0.046875 (24) 5.625 (24)
Cm101DadeJ 1.5 (24) 4 (24) 1.25 (24) 0.625 (24) 25 (216) 0.064 (216) 0.046875 (24) 5.625 (24)
Cm202DadeJ 1.5 (24) 4 (24) 1.25 (24) 0.625 (24) 25 (216) 0.064 (216) 0.046875 (24) 5.625 (24)
ADP1DcraA 1.5 (24) 8 (22) 5 (0) 2.5 (0) 400 (0) 1.024 (0) 0.1875 (0) 22.5 (0)
Cm201DcraA 1.5 (24) 8 (22) 5 (0) 2.5 (0) 400 (0) 1.024 (0) 0.1875 (0) 22.5 (0)
aFold change compared to wild-type MIC is given in brackets.
bCm: chloramphenicol; Et: Ethidium bromide; Bc: Benzalkonium chloride; Ch: Chlorhexidine; SDS: Sodium Dodecyl Sulfate; Nor: Norfloxacin; Tc: Tetracycline; Tm:
Trimenthoprim.
doi:10.1371/journal.pone.0056090.t003
Figure 3. Efflux of ethidium bromide by A. baylyi ADP1 cells.
Wild-type and mutant strains were loaded with 15 mM ethidium
bromide in the presence of the protonophore CCCP. Cells were
energised using 0.4% glucose at the point indicated by an arrow to
initiate efflux. Efflux was monitored fluorometrically using an excitation
wavelength of 530 nm and emission wavelength of 610 nm. Assays
were conducted in duplicate, and a representative experiment is
shown.
doi:10.1371/journal.pone.0056090.g003
Table 4. Fold changes in expression of multidrug efflux
systems in the chloramphenicol resistant mutant strains as
determined by qRT-PCR.
Strain Gene Upregulateda Fold Changeb
Cm101 ACIAD2944 5.2860.47
Cm102 ACIAD2944 5.2360.37
Cm103 ACIAD2944 5.5960.55
Cm201 ACIAD3292 34.4462.69
Cm202 ACIAD2944 7.7060.35
aLocus tag of A. baylyi ADP1 upregulated transporter.
bStandard deviation is shown.
The expression levels of the 46 putative efflux systems of ADP1 was determined
by qRT-PCR to identify those that were upregulated in the mutant strains.
Those showing greater than 5 fold-upregulation are included in the table.
doi:10.1371/journal.pone.0056090.t004
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Figure 4. Bayesian tree depicting phylogenetic relationships of putative drug exporting RND superfamily transporters identified
within the genomes of sequenced Acinetobacter spp. (as determined using TransAAP). Also included are previously characterized transporters
classified within the Hydrophobe/Amphiphile Efflux-1 family of the RND superfamily, as listed in the Transporter Classification Database (www.tcdb.
org). The protein sequence of the A. baumannii ATCC 17978 RND efflux transporter from the Heavy Metal Efflux family, CzcA (A1S_2932), was used as
an out-group. Branch lengths are proportional to phylogenetic distance and the confidence of each node is indicated by posterior probabilities.
Proteins othologous to the major RND drug efflux systems encoded in Acinetobacter, AdeB, AdeJ and AdeG are indicated. Gray shaded boxes denote
clades that include orthologs from both A. baumannii and A. baylyi.
doi:10.1371/journal.pone.0056090.g004
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within the putative adeIJK operator region, highlighting similarities
between this A. baumannii strain and A. baylyi ADP1. However, it
was recently shown that that a TetR-like regulator, AdeN, is
responsible for the repression of the adeIJK operon in A. baumannii,
and that mutations within the adeN structural gene results in the
deprepression of adeJ in single-step mutants selected in vitro [19].
Therefore, considering the close phylogenetic similarities that A.
baylyi ADP1 adeJ shares with its A. baumannii counterpart (Fig. 4), it
is possible that the regulatory mechanisms which govern the
repression of the adeIJK operon in A. baylyi ADP1 share
mechanistic similarities with those recently described for A.
baumannii. The role of putative AdeN homologues in the regulation
of adeIJK in A. baylyi ADP1 warrants further investigation.
In contrast to the tripartite RND system AdeIJK, the CraA
MFS transporter is encoded by a single gene, which appears not to
reside in a bi- or multi-cistronic operon on the A. baylyi ADP1
chromosome. We sequenced a 486 bp region immediately
upstream of the craA ORF in order to identify mutations which
may affect the craA promoter or, potentially, an operator region of
the gene, in the craA upregulated strain, Cm201. Interestingly, this
sequencing strategy revealed a T to G substitution 12 base-pairs
upstream from the craA translation initiation codon. The
contribution of this mutation to multidrug resistance is intriguing,
since it does not appear to coincide with a potential craA
transcriptional promoter. A putative craA ribosome binding site
(RBS), AGTAG, can be observed seven base pairs upstream from
the craA translation initiation site, and resides immediately
adjacent to the mutated residue. However, the observed substi-
tution does not appear to extend or improve the putative RBS
sequence. No known regulatory motifs are present within the
vicinity of the mutation, although the mechanisms of transcrip-
tional regulation of the craA promoter, if any, remain to be
elucidated. The close proximity of the mutation to the putative
RBS suggests that that the mutated residue forms part of the 59
untranslated region (UTR) of the mature mRNA transcript.
T to G Substitution in craA 59 Upstream Region Increases
mRNA Transcript Stability
Mutations in the 59 UTR of efflux pump transcripts have been
shown induce multidrug resistance in Staphylococcus aureus [20],
Bacillus subtilis [21] and in Neiserria gonorrhoeae [22]. The presence of
a mutation in the 59 UTR of the gene transcripts of S. aureus norA,
B. subtilis bmr3 and N. gonorrhoeae mtrC-mtrD-mtrE correlates with an
increase in the half-life of the exporter gene mRNA. Despite the
fact these stabilising mutations lie 80–120 nt upstream of the
translation start site, and the mutation in Cm201 is only 12 nt
upstream of the translation start site, we investigated the stability
of craA mRNA in wild-type A. baylyi ADP1 and Cm201 cells using
qRT-PCR. These assays revealed that wild-type craA mRNA
transcripts decayed much more rapidly than that of the mutant
mRNA transcripts (Fig. 5), indicating that the T to G substitution
12 base pairs distal to translational start point of craA enhances
efflux pump transcript stability. The extrapolated wild-type craA
mRNA half-life was 24 min, whereas it was nearly 3-fold longer at
65 min in Cm201. It is unknown at this stage how this mutation in
the 59 UTR of the craA transcript contributes to mRNA stability.
Discussion
Infections involving Acinetobacter spp. are often difficult to treat,
owing to the organism’s propensity to rapidly and efficiently
acquire resistance genes from the environment, or by exploiting
their intrinsic resistance potential by overexpressing core resistance
factors, as observed in these investigations. Recent clinical isolates
of Acinetobacter baumannii have shown resistance to all useful
chemotherapeutic compounds, leading researchers to term this
state of intractability ‘pan-drug’ resistance [4].
Recently, the non-pathogenic soil-dwelling Acinetobacter species
A. baylyi ADP1 has been proposed as a novel model organism for
metabolic and genetic studies, since, amongst other traits, A. baylyi
ADP1 is highly recombinogenic and easily transformable. Initially,
we conducted a bioinformatic survey in order to determine the
conservation of multidrug efflux pumps across four divergent
species of the genus Acinetobacter, allowing us to determine the
general utility of A. baylyi ADP1 for the study of multidrug efflux.
Our bioinformatic survey indicated that more than 75% of the
putative efflux systems encoded in A. baylyi ADP1 were shared with
at least one of the A. baumannii strains, and approximately half (21
of 46) of these systems were shared with all other Acinetobacter
species analysed (Fig. 1). Of particular note, A. baylyi ADP1 shares
approximately 70 and 67% of its core genome efflux determinants
with clinical strains AYE and ATCC 17978 respectively. The high
level of conservation of efflux determinants between A. baylyi
ADP1 and the two clinical isolates was somewhat surprising, since
the accumulation of newer pre-formed efflux genes from other
closely related species in the hospital environment is a predom-
inant factor in the success of A. baumannii as a clinically important
species, and as such, it could be expected that the types of pumps
encoded by clinical species may differ significantly from that of a
primarily soil-dwelling organism.
In order to study the efflux response of A. baylyi ADP1 to
antimicrobial compounds, we adapted wild-type cells to 10 or
20 mg/ml chloramphenicol via a single-exposure selection assay.
Chloramphenicol was chosen for this assay since many clinical A.
baumannii strains exhibit intrinsic resistance to this drug [23], and
the basis of this resistance is likely to be due to antimicrobial efflux,
or the alteration of membrane permeability [23]. Results of our
Figure 5. Stability of craA mRNA transcript in wild-type and
Cm201 backgrounds.Wild-type and Cm201 cells were grown to mid-
logarithmic phase before transcription was arrested with the addition of
200 mg/ml rifampicin. Culture samples were harvested at time points
T = 0, 5, 10 and 20, before RNA was extracted and cDNA was
synthesised. qRT-PCR was conducted in duplicate using two biological
replicates, and the abundance of the craA transcript relative to the rpoB
transcript in transcriptionally arrested cells was determined. R2 values
and standard deviation is shown.
doi:10.1371/journal.pone.0056090.g005
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single-step selection assay showed that the reservoir of chloram-
phenicol resistant cells in populations of A. baylyi ADP1 is relatively
low, with only approximately 1 in every 100 million cells showing
resistance to chloramphenicol at or above the concentrations used.
However, the resistance phenotype exhibited by these selected
strains is indicative of an underlying presence of mutant cells in
Acinetobacter spp. populations, even in the absence of selection.
Bacterial growth assays using single-step chloramphenicol mutants
surprisingly showed that four of the five strains (Cm101, Cm102,
Cm103 and Cm201) adapted to tolerate higher concentrations of
chloramphenicol did not show a statistically significant difference
in growth rates compared to wild-type A. baylyi ADP1 (Table 2).
Cm201 did not exhibit a growth defect despite its upregluated
efflux determinant, craA, showing a ,34 fold increase in
transcription compared to wild-type A. baylyi ADP1 cells
(Table 4). On the other hand, the ,8 fold upregulation of adeJ
in Cm202 resulted in a significant growth defect (Fig. 2). The
upregulation of adeJ at lower levels (strains Cm101, Cm102,
Cm103; ,5.5 fold) did not result in a significant negative impact
to bacterial fitness, indicating that the ,5.5 fold upregulation of
adeJ may be approaching the upper limit for the transcription of
this gene without serious physiological consequences to the host.
Corroborating this observation, bacterial growth assays showed
that Cm202DadeJ grew at a rate which was not statistically
different to that of wild-type A. baylyi ADP1 cells (data not shown),
indicating that the ,8-fold upregulation of adeJ was responsible
for the deleterious effects observed. Previous studies have shown
that the overexpression of the AdeIJK complex in both A.
baumannii and E. coli is toxic to the host [16], and multidrug
resistant A. baumannii strains, either isolated clinically or selected in
vitro, have shown adeJ to be upregulated to an upper limit of
approximately 5–6 fold [18,24]. Our observations, in concert with
those reported by Rajamohan et al. [24], Coyne et al., [18], and
Damier-Piolle et al. [16] indicate that environmental and
evolutionary pressures are unlikely to select for Acinetobacter spp.
which harbour mutations which strongly upregulate the transcrip-
tion of adeJ, possibly due to the detrimental impact on overall cell
fitness.
MIC analyses showed strains in which adeJ was upregulated
were resistant to a wider range of antiseptics and disinfectants than
Cm201, in which craA was upregulated. These data largely
corroborate previous results describing substrate recognition
profiles for both transporters [16]; adeJ, and [17]; craA, however,
one key difference in substrate specificity can be noted. Damier-
Piolle et al. [16] reported that ethidium bromide could not be
transported by the AdeIJK system in A. baumannii, whereas in our
study, A. baylyi ADP1 adeJ mutant strains show both an increase in
ethidium bromide MIC (Table 3) and in the active transport of the
compound (Fig. 3).With respect to CraA, our observations for the
strong substrate specificity towards chloramphenicol of this
transporter were in accordance with those reported by Roca et
al. [17]. However, in this work we determined that ethidium
bromide is also a substrate of this efflux protein, demonstrating
that CraA is a multidrug efflux system.
It is noteworthy that the MIC for ethidium bromide in the craA
upregulated strain Cm201 was much lower than that of the adeJ
mutant strains, despite the high rate of ethidium bromide efflux
observed for this strain. However, the transport experiments show
only the initial rate of ethidium efflux from cells pre-loaded with a
sub-MIC concentration of ethidium, and may not directly reflect
the final resistance level of the cells. Cells overexpressing the
AdeIJK efflux system may, for a number of reasons, be able to
maintain a higher ethidium concentration gradient across their
membranes than cells overexpressing CraA, despite the apparently
slower initial rate of efflux. Most importantly, the AdeIJK
tripartite complex spans both the inner and outer membranes of
Acinetobacter cells, and facilitates substrate transport into the
extracellular matrix [25], whereas, CraA is likely to move
substrates into the periplasmic space. Over time the substrate
that has accumulated in the periplasm may more readily re-enter
the cytoplasm by diffusion than the substrates transported into the
extracellular matrix by the AdeIJK system [27].
Differences in the initial ethidium efflux rates may also be
related to the location of substrate capture by the respective
transport systems. MFS transporters, such as CraA, are likely to
capture their substrates from within the cytoplasm or inner-leaflet
of the inner-membrane, whereas RND efflux systems, such as
AdeIJK, may exclusively, or at least primarily, capture substrates
from within the periplasmic space and not from the cytosol
[26,27]. Therefore, in cells over-expressing adeIJK, the movement
of ethidium out of the cytosol is still reliant on either passive
diffusion or on the action of simple transporters, which were not
expressed above background levels in the adeIJK over-expression
strains.
We sought to determine the genetic basis for the upregulation of
adeJ and craA in the mutant strains. From the results of
transcription analyses (Table 4), we speculated that at least three
different mutations are present within the selected A. baylyi ADP1
single-step mutants, since 1) Cm201 upregulates a different
transporter compared to the other selected strains and 2) Cm202
upregulates adeJ to a higher level than the other strains in which
adeJ is upregulated. However, sequencing the promoter and
intergenic regions in adeJ upregulated strains did not reveal any
mutations, suggesting that a mutation in a global regulator of the
AdeIJK efflux pump may be responsible for the upregulation of
transcription in these strains. Indeed, a recent report describes a
TetR-like regulator, AdeN, which is responsible for the regulation
of adeIJK in A. baumannii [19]. The role of AdeN in the regulation
of adeIJK in A. baylyi ADP1 remains to be determined, and
warrants further investigation. However, if a homologue of AdeN
does indeed regulate adeIJK in A. baylyi ADP1, mutations arising in
adeN in Cm202 may differ from those affecting Cm101, Cm102,
and Cm103, since adeJ in Cm202 is upregulated to a higher level
compared that of the other strains in which adeJ is upregulated.
Alternatively, adeIJK may be subject to more than one level of
regulation in A. baylyi ADP1, thus accounting for the higher level
of adeJ transcription observed in Cm202.
In contrast, sequencing the region upstream from the craA ORF
revealed a T to G substitution 12 basepairs upstream from the
predicted craA initiation codon. A putative craA RBS, AGTAG,
can be observed in this region, but the upstream mutation does not
appear to extend or improve the craA RBS. In light of other work
which describes mRNA stabilising mutations in the 59 UTR of
efflux transcripts [20,21,22], we explored the ability of the T to G
substitution in the putative craA transcript to increase the craA
mRNA half-life. Using a qRT-PCR based assay, the craA mutant
transcript was determined to be approximately 2.7 fold more
stable than craA mRNA from wild-type cells. However, the precise
mechanism of increased craA mRNA stability in Cm201 cells is
unknown. The generation of stable stem-loop structures within the
59 UTR mRNA of mutant bmr3 and norA efflux pump transcripts
has been suggested as the basis for the observed stability of these
transcripts. Similarly, it is tempting to speculate that an analogous
mechanism may be responsible for the observed increase in craA
mRNA stability. However, the relative locations of the bmr3 and
norA mutations are significantly more distal in each respective
transcript than that described for craA here, and as such this
mutation may constitute a novel means by which craA mRNA
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stability is enhanced. Alternatively, since the binding of ribosomes
to the mRNA transcript has also been shown to have a role in the
protection of the transcript from degradation [28], it is a possibility
that this mechanism is responsible for the observed increase in craA
stability. Even though it is not immediately evident how the craA
mutation may enhance or improve the RBS, it is feasible that the
presence of this mutation in the immediate location of the RBS
may alter ribosomal binding, thus enhancing craA stability.
In summary, we have presented evidence to support the use of
the non-pathogenic bacterium A. baylyi ADP1 in studies of
multidrug efflux. Using this organism, which has a lower level of
intrinsic resistance than other strains of Acinetobacter associated with
nosocomial infections, we have shown how Acinetobacter spp. can
rapidly adapt to the use of antibacterial chemotherapies via the
selection of mutant cells which pre-exist in A. baylyi ADP1
populations. Remarkably, no less than three different mutations
were selected for amongst five different isolates, indicating a high-
level of redundancy of multidrug resistance determinants em-
ployed by Acinetobacter spp., and a propensity for these strains to
acquire mutations that lead to drug resistance phenotypes. This
rapid and diverse response of Acinetobacter spp. to antibiotic
challenge may explain the emergence of Acinetobacter spp. as an
intractable clinical pathogen. Indeed, the increasing importance of
multidrug resistant Acinetobacter spp. in clinical settings requires
novel methods for studies into this growing problem. The
genetically malleable organism A. baylyi ADP1 may fulfil this
developing requirement.
Materials and Methods
Bacterial Strains, Media and Reagents
A. baylyi ADP1 type strain 33305 was obtained from the
American Type Culture Collection (ATCC). A. baylyi ADP1 strains
were routinely cultured in LB broth supplemented with 5 mg/ml
chloramphenicol for single-step mutants or 25 mg/ml kanamycin
for allelic replacement derivatives. Culture on solid media was
conducted using Nutrient Agar (NA) supplemented with antibiot-
ics at the concentration listed above where required. Bacterial
growth assays and MIC analyses were carried out using Mueller-
Hinton (MH) broth. Chemicals were purchased from Sigma-
Aldrich. Oligonucleotides were obtained from Integrated DNA
Technologies, USA, or Sigma-Aldrich, Australia. DNA was
amplified in PCR using KOD Hot Start DNA Polymerase
(Toyobo Corporation, Japan).
Bioinformatic Analyses
Efflux proteins encoded by Acinetobacter spp. were identified using
the Transporter Automated Analysis Pipeline (TransAAP; www.
membranetransport.org) [15]. DNA and deduced amino acid
sequences were downloaded from relevant Acinetobacter spp. genome
databases within the National Center for Biotechnology Informa-
tion (NCBI; blast.ncbi.nlm.nih.gov/). BLAST analyses were
undertaken using the suite of online alignment tools available
from NCBI. Construction of phylogenetic trees was undertaken
using MrBayes software version 3.1.2 based on protein alignments
made using ClustalX version 2.0.12. Orthologous efflux systems
from different Acinetobacter strains were identified by multiway best-
match BlastP analyses, using E-value limit of 1025 to designate
putative orthologs. Percent identity and similarity were deter-
mined using MatGAT (Matrix Global Alignment Tool) v 2.02
[29].
Generation of mutant A. baylyi ADP1 strains
A. baylyi single-step mutants were generated by plating 100 ml
(2.086108 CFU) of wild-type A. baylyi ADP1 cells from an
overnight culture directly onto NA containing either 10 or
20 mg/ml chloramphenicol. Mutant strains were named as per
Table 1. For the generation of A. baylyi ADP1 allelic replacement
strains, a method similar to that of Metzgar et al. [2] was
employed, using a kanamycin resistance cassette as a selectable
marker. Primers used in alleic replacement studies are given in
Table 1.
Bacterial Growth Assays
Wild-type A. baylyi ADP1 and single-step mutants were struck
for single colonies on NA or NA containing chloramphenicol
5 mg/ml where required. A single colony from each strain was
separately inoculated into 5 ml antibiotic-free MH broth and
grown with shaking at 37uC for 16 hours. Saturated overnight
cultures of A. baylyi ADP1 strains were used to inoculate fresh MH
broth to an OD600 of 0.01 in a volume of 200 ml in a clear plastic
flat-bottomed 96-well microplate (Costar, USA). Bacterial growth
assays were conducted using a SPECTROstar Nano spectropho-
tometer (BMG Labtech) equipped with temperature-regulated
heating plate at 37uC with shaking in a double-orbital motion. Cell
growth was monitored over a time course of 15 hours. Assays were
conducted in duplicate using three biological replicates. Doubling
times were calculated by plotting the linear regression of the
natural log of the optical density against time during exponential
growth phase. Differences in growth rates between wild-type and
mutant strains were determined using the paired Student’s t-test,
with a P-value of 0.025 as the cut-off for statistical significance.
MIC assays
MIC analyses were conducted using the two-fold broth dilution
method described by Wiegland et al., 2008 [30]. Briefly, 96-well
flat-bottomed microplates were prepared for MIC analyses by
inoculating appropriate wells with 200 ml MH broth containing
two-fold dilutions of test compounds. A. baylyi ADP1 cells grown to
an OD600 of 0.6 were inoculated into MH containing wells, before
microplates were incubated for 16 hours at 37uC with shaking.
The presence of bacterial growth in each well was determined at
OD600 using a SPECTROstar Nano microplate reader (BMG
Labtech, USA). A two-fold change in MIC was considered to be a
significant indicator of resistance.
Fluorimetric transport assays
10 mL cultures of wild-type A. baylyi ADP1 cells or A. baylyi
ADP1 single-step mutants were grown without selection to mid-
logarithmic phase in LB. Cells were collected by centrifugation
and were washed twice with 10 mL 20 mM HEPES buffer (pH 7).
Washed cells were resuspended in 10 mL 20 mM HEPES (pH 7)
to an OD600 of 0.6. 1 mL aliquots of cells were loaded with 15 mM
ethidium bromide in the presence of 10 mM of the protonophore
CCCP at 37uC for 1 hour. Ethidium bromide loaded cells were
collected by centrifugation and washed three times in 20 mM
HEPES (pH 7). Cells were reenergised with the addition of 0.4%
glucose, and the rate of ethidium bromide export was monitored
fluorimetrically using a Perkin Elmer LS 55 fluorescence
spectrophotometer over a time course of 600 seconds using
excitation and emission wavelengths of 530 nm and 610 nm,
respectively.
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qRT-PCR and mRNA stability assays
qRT-PCR was employed as a high-throughput preliminary
means of determining the gene/s responsible for antimicrobial
efflux in A. baylyi ADP single-step mutants. Oligonucleotide
primers were designed to target each of the putative efflux pumps
identified by TransAAP to be encoded within the A. baylyi genome.
Nucleotide sequences encoding efflux pumps were downloaded
from NCBI, and the online primer design program BatchPrimer3
(v1.0; http://probes.pw.usda.gov/batchprimer3/) was used to aid
in oligonucleotide design [31]. Parameters for qRT-PCR oligo-
nucleotide design included: 20 bp length, melting temperature
(Tm) of ,57uC, and amplicon size of ,200 bp. BatchPrimer3
designed oligonucleotides are listed in Table S1. For qRT-PCR
analyses, bacterial cells were grown to mid-logarithmic phase in
the absence of antibiotic selection, and total RNA was extracted
using the PureLinkTM RNA Mini Kit (Invitrogen). Approximately
1 mg of total RNA was reverse-transcribed to cDNA using the
SuperScriptH VILOTM cDNA Synthesis Kit (Invitrogen). qRT-
PCR was conducted in an Eppendorf MastercyclerH ep realplex
thermal cycler, using GoTaqTM qPCR Master Mix (Promega).
Relative abundance of amplicon products was determined using
the comparative CT (cycle threshold; DDCT) method [32],
normalised against the transcription of the constitutively tran-
scribed rpoB gene. Global qRT-PCR analysis was conducted at
least once for each efflux pump primer pair, and qRT-PCR for
pumps showing significant upregulation (.5 fold; adeJ and craA)
was conducted in quadruplicate.
For craA mRNA stability studies, A. baylyi ADP1 cultures were
grown to mid-logarithmic phase before transcription was arrested
with the addition of 200 mg/ml rifampicin. Culture samples were
harvested by centrifugation at time points T= 0, 5, 10 and
20 minutes and were immediately snap frozen in liquid nitrogen,
prior to storage at 280uC until processing. RNA extraction,
cDNA synthesis, and qRT-PCR were conducted essentially as
above. The relative abundance of the craA transcript relative to the
rpoB transcript in transcriptionally arrested cells over the time
course indicated was calculated using the DDCT method.
Experiments were conducted in duplicate using two biological
replicates.
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